ADC Therapeutics SA (ADCT) Insider Trading

Name: ADC Therapeutics SA (ADCT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 2, 2026): Mohamed Zaki (Chief Medical Officer): Grant/Award of 213,900 shares.

Get alerted when insiders trade ADCT

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta